☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Emerge
The US FDA's Advisory Panel Slams Biogen's Aducanumab for Alzheimer's Disease
November 9, 2020
Biogen and Eisai Terminate P-III ENGAGE and EMERGE Study for Alzheimer's Disease
March 22, 2019
20 Contract Development and Manufacturing Organizations (CDMOs) of 2022
December 5, 2023
Mainz Biomed Collaborates with Liquid Biosciences to Develop AI Enables Screening Tests for Colorectal Cancer
November 10, 2023
Simon Portsmouth Shares Insights from P-III Trial of Ensitrelvir for the Prevention of Symptomatic SARS-CoV-2 Infection
September 18, 2023
PharmaShots Weekly Snapshots (February 13 - 17, 2023)
February 17, 2023
Bavarian Nordic to Acquire Emergent BioSolutions’ Vivotif, Vaxchora and an Under Developed Chikungunya Vaccine
February 15, 2023
Visby Medical’s Respiratory Health Test Receives Emergency Use Authorization from the US FDA
January 4, 2023
Load more...
Back to Home
Modal title
×
Modal body text goes here.